Group B streptococcal immunisation of pregnant women for the prevention of early and late onset Group B streptococcal infection of the neonate as well as adult disease

References

• Lancefield RC, Hare R. The serological differentiation of pathogenic and non-pathogenic strains of hemolytic streptococci from parturient women. J Exp Med. 1935;61(3):335–349.
   PubMedGoogle Scholar
• Eickhoff TC, Klein JO, Daly AK, et al. Neonatal sepsis and other infections due to group b beta-hemolytic streptococci. N Engl J Med. 1964;271:1221–1228.
   PubMed Web of Science ®Google Scholar
• Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11(3):497–513.
   PubMed Web of Science ®Google Scholar
• Towers CV, Rumney PJ, Asrat T, et al. The accuracy of late third-trimester antenatal screening for group B streptococcus in predicting colonization at delivery. Am J Perinatol. 2010;27(10):785–790.
   PubMed Web of Science ®Google Scholar
• Lin FY, Weisman LE, Azimi P, et al. Assessment of intrapartum antibiotic prophylaxis for the prevention of early-onset group B Streptococcal disease. Pediatr Infect Dis J. 2011;30(9):759–763.
   PubMed Web of Science ®Google Scholar
• El Helali N, Nguyen JC, Ly A, et al. Diagnostic accuracy of a rapid real-time polymerase chain reaction assay for universal intrapartum group B streptococcus screening. Clin Infect Dis. 2009;49(3):417–423.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Shah VS. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev. 2014;6:CD007467.
   PubMed Web of Science ®Google Scholar
• Porta K, Rizzolo D. Preventing group B streptococcal infections in newborns. Jaapa. 2015;28(3):24–29.
   PubMedGoogle Scholar
• Pintye J, Saltzman B, Wolf E, et al. Risk factors for late-onset Group B streptococcal disease before and after implementation of universal screening and intrapartum antibiotic prophylaxis. J Pediatric Infect Dis Soc. 2015. PMID 26501472 Oct 12. pii: piv067. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Bekker V, Bijlsma MW, Van De Beek D, et al. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014;14(11):1083–1089.
   PubMed Web of Science ®Google Scholar
• Eastwood KA, Craig S, Sidhu H, et al. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience. BJOG. 2015;122(3):361–367.
   PubMed Web of Science ®Google Scholar
• Edwards RK, Tang Y, Raglan GB, et al. Survey of American obstetricians regarding group B streptococcus: opinions and practice patterns. Am J Obstet Gynecol. 2015;213(2):229 e1–7.
   PubMed Web of Science ®Google Scholar
• Petersen KB, Johansen HK, Rosthoj S, et al. Increasing prevalence of group B streptococcal infection among pregnant women. Dan Med J. 2014;61(9):A4908.
   PubMed Web of Science ®Google Scholar
• Todorova-Christova M, Vacheva R, Decheva A, et al. A study on early-onset neonatal group B streptococcal infection, Bulgaria, 2007–2011. Arch Pediatr. 2014;21(9):953–960.
   PubMed Web of Science ®Google Scholar
• Verani JR, Spina NL, Lynfield R, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol. 2014;123(4):828–837.
   PubMed Web of Science ®Google Scholar
• Verani JR, McGee L, Schrag SJ. Division of bacterial diseases NCfI, respiratory diseases CfDC, prevention. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recommend Rep. 2010;59(RR–10):1–36.
   PubMedGoogle Scholar
• Berardi A, Cattelani C, Creti R, et al. Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination. Expert Rev Anti Infect Ther. 2015;13(11):1387–1399.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Barrett FF, Gordon RC, et al. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr. 1973;82(4):724–729.
   PubMed Web of Science ®Google Scholar
• Niduvaje K, Amutha C, Roy J. Early neonatal streptococcal infection. Indian J Pediatr. 2006;73(7):573–576.
   PubMedGoogle Scholar
• Baker CJ. Group B streptococcal infections. In: Stoll BJ, editor. Clinics in perinatology infections in perinatology. Vol 24. Philadelphia: WB Saunders; 1997. p. 59–70.
   Google Scholar
• Schuchat A, Aver-Robinson K, Plikaytis BD, et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The active surveillance study group. Pediatr Infect Dis J. 1994;13(7):623–629.
   PubMed Web of Science ®Google Scholar
• Adams WG, Kinney JS, Schuchat A, et al. Outbreak of early onset group B streptococcal sepsis. Pediatr Infect Dis J. 1993;12(7):565–570.
   PubMed Web of Science ®Google Scholar
• Dillon HC Jr, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr. 1987;110(1):31–36.
   PubMed Web of Science ®Google Scholar
• Tuppurainen N, Hallman M. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients. Obstet Gynecol. 1989;73(4):583–587.
   PubMed Web of Science ®Google Scholar
• Cutland CL, Schrag SJ, Thigpen MC, et al. Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004–2008(1). Emerg Infect Dis. 2015;21(4):638–645.
   PubMed Web of Science ®Google Scholar
• Dangor Z, Kwatra G, Izu A, et al. HIV-1 Is associated with lower Group B streptococcus capsular and surface-protein IgG antibody levels and reduced transplacental antibody transfer in pregnant women. J Infect Dis. 2015;212(3):453–462.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992;90(5):775–778.
   PubMed Web of Science ®Google Scholar
• CDC Centers for Disease and Prevention. Perinatal group B streptococcal disease after universal screening recommendations–United States, 2003–2005. MMWR Morb Mortal Wkly Rep. 2007;56(28):701–705.
   PubMedGoogle Scholar
• Sinha A, Lieu TA, Paoletti LC, et al. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. Vaccine. 2005;23(24):3187–3195.
   PubMed Web of Science ®Google Scholar
• Anthony BF, Eisenstadt R, Carter J, et al. Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis. 1981;143(6):761–766.
   PubMed Web of Science ®Google Scholar
• Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol. 1996;88(5):811–815.
   PubMed Web of Science ®Google Scholar
• Boyer KM, Gadzala CA, Burd LI, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis. 1983;148(5):795–801.
   PubMed Web of Science ®Google Scholar
• Larsen JW, Dooley SL. Group B streptococcal infections: an obstetrical viewpoint. Pediatrics. 1993;91(1):148–149.
   PubMed Web of Science ®Google Scholar
• Morbidity, Mortality Weekly Review. Prevention of perinatal group B streptococcal disease: a public health perspective. Atlanta (GA): CDC Centers for Disease and Prevention; 1996.
   Google Scholar
• Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347(4):233–239.
   PubMed Web of Science ®Google Scholar
• Brozanski BS, Jones JG, Krohn MA, et al. Effect of a screening-based prevention policy on prevalence of early-onset group B streptococcal sepsis. Obstet Gynecol. 2000;95(4):496–501.
   PubMed Web of Science ®Google Scholar
• Bronfort G, Haas M, Evans R, et al. Effectiveness of manual therapies: the UK evidence report. Chiropr Osteopat. 2010;18:3.
   PubMedGoogle Scholar
• Factor SH, Levine OS, Nassar A, et al. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol. 1998;179(6 Pt 1):1568–1571.
   PubMed Web of Science ®Google Scholar
• Gilson GJ, Christensen F, Romero H, et al. Prevention of group B streptococcus early-onset neonatal sepsis: comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks’ gestation. J Perinatol. 2000;20(8 Pt 1):491–495.
   PubMedGoogle Scholar
• Hafner E, Sterniste W, Rosen A, et al. Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol. 1998;179(3 Pt 1):677–681.
   PubMed Web of Science ®Google Scholar
• Jeffery HE, Moses LM. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics. 1998;101(1):E2.
   PubMed Web of Science ®Google Scholar
• Katz VL, Moos MK, Cefalo RC, et al. Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. Am J Obstet Gynecol. 1994;170(2):521–526.
   PubMed Web of Science ®Google Scholar
• Lieu TA, Mohle-Boetani JC, Ray GT, et al. Neonatal group B streptococcal infection in a managed care population. Perinatal Group B streptococcal infection study group. Obstet Gynecol. 1998;92(1):21–27.
   PubMed Web of Science ®Google Scholar
• Bromberger P, Lawrence JM, Braun D, et al. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics. 2000;106(2 Pt 1):244–250.
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002;100(6):1405–1412.
   PubMedGoogle Scholar
• Quan V, Verani JR, Cohen C, et al. Invasive Group B streptococcal disease in South Africa: importance of surveillance methodology. Plos One. 2016;11(4):e0152524.
   PubMed Web of Science ®Google Scholar
• Bjorklund V, Nieminen T, Ulander VM, et al. Replacing risk-based early-onset-disease prevention with intrapartum group B streptococcus PCR testing. J Maternal Fetal. 2016;1–6 [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Darlow B, Campbell N, Austin N, et al. The prevention of early-onset neonatal group B streptococcus infection: New Zealand Consensus Guidelines 2014. N Z Med J. 2015;128(1425):69–76.
   PubMed Web of Science ®Google Scholar
• Cools P, Jespers V, Hardy L, et al. A multi-country cross-sectional study of vaginal carriage of Group B Streptococci (GBS) and Escherichia coli in resource-poor settings: prevalences and risk factors. Plos One. 2016;11(1):e0148052.
   PubMed Web of Science ®Google Scholar
• And RCoO, Gynaecologists. The prevention of early onset neonatal Group B streptococcal disease. Greentop guidelines number 36. RCOG Press; 2012.
   Google Scholar
• Morbidity, Mortality Weekly Review. Prevention of perinatal Group B streptococcal disease. Atlanta (GA): CDC Centers for Disease and Prevention; 2002.
   Google Scholar
• Easmon CS. The carrier state: group B streptococcus. J Antimicrob Chemother. 1986;18(Suppl A):59–65.
   PubMed Web of Science ®Google Scholar
• Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004;363(9405):292–294.
   PubMed Web of Science ®Google Scholar
• Royal College of O, Gynaecologists. Prevention of early onset neonatal Group B streptococcal disease. Greentop guidelines number 36. RCOG Press; 2003.
   Google Scholar
• Berthier A, Sentilhes L, Hamou L, et al. Antibiotics at term. Questions about five severe allergic accidents. Gynecol Obstet Fertil. 2007;35(5):464–472.
   PubMed Web of Science ®Google Scholar
• Dunn AB, Blomquist J, Khouzami V. Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. J Reprod Med. 1999;44(4):381–384.
   PubMed Web of Science ®Google Scholar
• Jao MS, Cheng PJ, Shaw SW, et al. Anaphylaxis to cefazolin during labor secondary to prophylaxis for group B Streptococcus: a case report. J Reprod Med. 2006;51(8):655–658.
   PubMed Web of Science ®Google Scholar
• Weiss ME, Adkinson NF. Immediate hypersensitivity reactions to penicillin and related antibiotics. Clin Allergy. 1988;18(6):515–540.
   PubMedGoogle Scholar
• Chaudhuri K, Gonzales J, Jesurun CA, et al. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth. 2008;17(4):350–357.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347(4):240–247.
   PubMed Web of Science ®Google Scholar
• Moore MR, Schrag SJ, Schuchat A. Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis. 2003;3(4):201–213.
   PubMed Web of Science ®Google Scholar
• Edwards RK, Clark P, Sistrom CL, et al. Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens. Obstet Gynecol. 2002;100(3):534–539.
   PubMed Web of Science ®Google Scholar
• Matteson KA, Lievense SP, Catanzaro B, et al. Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy. Obstet Gynecol. 2008;111(2 Pt 1):356–364.
   PubMed Web of Science ®Google Scholar
• Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. Jama. 2008;299(17):2056–2065.
   PubMed Web of Science ®Google Scholar
• Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360(25):2626–2636.
   PubMed Web of Science ®Google Scholar
• Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Hum Vaccin. 2008;4(6):444–448.
   PubMed Web of Science ®Google Scholar
• Betriu C, Gomez M, Sanchez A, et al. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother. 1994;38(9):2183–2186.
   PubMed Web of Science ®Google Scholar
• Cunningham R, Walker C, Ridgway E. Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcus. J Infect. 1992;25(1):77–81.
   PubMed Web of Science ®Google Scholar
• Severin MJ, Wiley JL. Change in susceptibility of group B streptococci to penicillin G from 1968 through 1975. Antimicrob Agents Chemother. 1976;10(2):380–381.
   PubMed Web of Science ®Google Scholar
• Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol. 1998;92(2):258–261.
   PubMed Web of Science ®Google Scholar
• Dahesh S, Hensler ME, Van Sorge NM, et al. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008;52(8):2915–2918.
   PubMed Web of Science ®Google Scholar
• Seki T, Kimura K, Reid ME, et al. High isolation rate of MDR group B streptococci with reduced penicillin susceptibility in Japan. J Antimicrob Chemother. 2015;70(10):2725–2728.
   PubMed Web of Science ®Google Scholar
• Nguyen ML, Toye B, Kanji S, et al. Risk factors for and outcomes of bacteremia caused by extended-spectrum ss-lactamase-producing Escherichia coli and klebsiella species at a canadian tertiary care hospital. Can J Hosp Pharm. 2015;68(2):136–143.
   PubMedGoogle Scholar
• Manning SD, Foxman B, Pierson CL, et al. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol. 2003;101(1):74–79.
   PubMed Web of Science ®Google Scholar
• Andrews JI, Diekema DJ, Hunter SK, et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am J Obstet Gynecol. 2000;183(4):859–862.
   PubMed Web of Science ®Google Scholar
• Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother. 1998;42(6):1517–1519.
   PubMed Web of Science ®Google Scholar
• Lin FY, Azimi PH, Weisman LE, et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis. 2000;31(1):76–79.
   PubMed Web of Science ®Google Scholar
• Bland ML, Vermillion ST, Soper DE, et al. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am J Obstet Gynecol. 2001;184(6):1125–1126.
   PubMed Web of Science ®Google Scholar
• Barcaite E, Bartusevicius A, Tameliene R, et al. Prevalence of maternal group B streptococcal colonisation in European countries. Acta Obstet Gynecol Scand. 2008;87(3):260–271.
   PubMed Web of Science ®Google Scholar
• Frohlicher S, Reichen-Fahrni G, Muller M, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Wkly. 2014;144:w13935.
   PubMedGoogle Scholar
• Schuchat A. Group B streptococcus. Lancet. 1999;353(9146):51–56.
   PubMed Web of Science ®Google Scholar
• Robbins JB, Schneerson R, Vann WF, et al. Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines. Ann NY Acad Sci. 1995;754:68–82.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999;179(1):142–150.
   PubMed Web of Science ®Google Scholar
• Levy C, Bonacorsi S, Bechet S, et al. Late-onset Group B streptococcal meningitis, potential effectiveness of a vaccine by maternal immunization? Pediatr Infect Dis J. 2015;34(9):1039.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Rench MA, Baker CJ. Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J. 2015;34(5):538–539.
   PubMed Web of Science ®Google Scholar
• Ikebe T, Chiba K, Shima T, et al. Evaluation of streptococcal toxic shock-like syndrome caused by group B streptococcus in adults in Japan between 2009 and 2013. J Infect Chemother. 2015;21(3):207–211.
   PubMed Web of Science ®Google Scholar
• Colbourn T, Asseburg C, Bojke L, et al. Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses. Health Technol Assess. 2007;11(29):1–226, iii.
   PubMed Web of Science ®Google Scholar
• Mohle-Boetani JC, Schuchat A, Plikaytis BD, et al. Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. Jama. 1993;270(12):1442–1448.
   PubMed Web of Science ®Google Scholar
• White A, Madhi SA. Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries. Vaccine. 2015;33(47):6396–6400.
   PubMed Web of Science ®Google Scholar
• Rubens CE, Wessels MR, Heggen LM, et al. Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci USA. 1987;84(20):7208–7212.
   PubMed Web of Science ®Google Scholar
• Imperi M, Pataracchia M, Alfarone G, et al. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80(2):212–214.
   PubMed Web of Science ®Google Scholar
• Yao K, Poulsen K, Maione D, et al. Capsular gene typing of Streptococcus agalactiae compared to serotyping by latex agglutination. J Clin Microbiol. 2013;51(2):503–507.
   PubMed Web of Science ®Google Scholar
• Lancefield RC. A serological differentiation of specific types of bovine hemolytic streptococci (group B). J Exp Med. 1934;59(4):441–458.
   PubMedGoogle Scholar
• Lancefield RC. Two serological types of group b hemolytic streptococci with related, but not identical, type-specific substances. J Exp Med. 1938;67(1):25–40.
   PubMedGoogle Scholar
• Lancefield RC, Freimer EH. Type-specific polysaccharide antigens of group B streptococci. J Hyg (Lond). 1966;64(2):191–203.
   PubMedGoogle Scholar
• Baker CJ, Kasper DL. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N Engl J Med. 1976;294(14):753–756.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Barrett FF. Group B streptococcal infections in infants. The importance of the various serotypes. Jama. 1974;230(8):1158–1160.
   PubMed Web of Science ®Google Scholar
• Wenger JD, Hightower AW, Facklam RR, et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The bacterial meningitis study group. J Infect Dis. 1990;162(6):1316–1323.
   PubMed Web of Science ®Google Scholar
• Blumberg HM, Stephens DS, Modansky M, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis. 1996;173(2):365–373.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Dwyer DM, Johnson JA. Emergence of serotype V group B streptococcal infection among infants and adults. J Infect Dis. 1995;171(2):513.
   PubMed Web of Science ®Google Scholar
• Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr. 1993;122(4):638–640.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Edwards MS, et al. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988;319(18):1180–1185.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med. 1990;322(26):1857–1860.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Edwards MS, Kasper DL. Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest. 1978;61(4):1107–1110.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003;21(24):3468–3472.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis. 1985;7(4):458–467.
   PubMedGoogle Scholar
• Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996;98(10):2308–2314.
   PubMed Web of Science ®Google Scholar
• Zaleznik DF, Rench MA, Hillier S, et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis. 2000;30(2):276–281.
   PubMed Web of Science ®Google Scholar
• Davies HD, Raj S, Adair C, et al. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J. 2001;20(9):879–884.
   PubMed Web of Science ®Google Scholar
• Farley MM. Group B streptococcal disease in nonpregnant adults. Clin Infect Dis. 2001;33(4):556–561.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland emerging infections program. J Infect Dis. 1998;177(4):998–1002.
   PubMed Web of Science ®Google Scholar
• Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study–1996. Sentinel health unit surveillance system site coordinators. J Infect Dis. 2000;182(1):168–173.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Rench MA, et al. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004;189(6):1103–1112.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Paoletti LC, et al. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007;25(1):55–63.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Paoletti LC, Rench MA, et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis. 2000;182(4):1129–1138.
   PubMed Web of Science ®Google Scholar
• Baker CJ, Rench MA, Fernandez M, et al. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003;188(1):66–73.
   PubMed Web of Science ®Google Scholar
• Palazzi DL, Rench MA, Edwards MS, et al. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis. 2004;190(3):558–564.
   PubMed Web of Science ®Google Scholar
• Paoletti LC, Rench MA, Kasper DL, et al. Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines. Infect Immun. 2001;69(11):6696–6701.
   PubMed Web of Science ®Google Scholar
• Paoletti LC, Madoff LC. Vaccines to prevent neonatal GBS infection. Semin Neonatol. 2002;7(4):315–323.
   PubMedGoogle Scholar
• Paoletti LC, Madoff LC, Kasper DL. Surface structures of Group B, streptococcus important in human immunity. In: Fischetti VA, Novick RP, Ferretti JJ, Portony DA, Rodd JI, editors. Gram positive pathogens. Washington (DC): ASM Press; 2000. p. 137–153.
   Google Scholar
• Lachenauer CS, Kasper DL, Shimada J, et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis. 1999;179(4):1030–1033.
   PubMed Web of Science ®Google Scholar
• Wang YH, Lu CC, Chiu CH, et al. Genetically diverse serotypes III and VI substitute major clonal disseminated serotypes Ib and V as prevalent serotypes of Streptococcus agalactiae from 2007 to 2012. J Microbiol Immunol Infect. 2015;1–6 [Epub ahead of print].
   Google Scholar
• Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine. 2013;31(Suppl 4):D13–9.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cutland CL, Jose L, et al. Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial. Lancet Infect Dis. 2016;1–6 [Epub ahead of print].
   Web of Science ®Google Scholar
• Paoletti LC, Guttormsen HK, Christian MS, et al. Neither antibody to a group B streptococcal conjugate vaccine nor the vaccine itself is teratogenic in rabbits. Hum Vaccin. 2008;4(6):435–443.
   PubMed Web of Science ®Google Scholar
• Miller JK. The prevention of neonatal tetanus by maternal immunization. J Trop Pediatr Environ Child Health. 1972;18(2):159–167.
   PubMedGoogle Scholar
• Lindahl G, Stalhammar-Carlemalm M, Areschoug T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev. 2005;18(1):102–127.
   PubMed Web of Science ®Google Scholar
• Rappuoli R. Reverse vaccinology. Cur Ropin Microbiol. 2000;3(5):445–450.
   PubMed Web of Science ®Google Scholar
• Giuliani MM, Adu-Bobie J, Comanducci M, et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A. 2006;103(29):10834–10839.
   PubMed Web of Science ®Google Scholar
• Johri AK, Paoletti LC, Glaser P, et al. Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol. 2006;4(12):932–942.
   PubMed Web of Science ®Google Scholar
• Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science. 2000;287(5459):1816–1820.
   PubMed Web of Science ®Google Scholar
• Maione D, Margarit I, Rinaudo CD, et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science. 2005;309(5731):148–150.
   PubMed Web of Science ®Google Scholar
• Sette A, Rappuoli R. Reverse vaccinology: developing vaccines in the era of genomics. Immunity. 2010;33(4):530–541.
   PubMed Web of Science ®Google Scholar
• Soriani M, Telford JL. Relevance of pili in pathogenic streptococci pathogenesis and vaccine development. Future Microbiol. 2010;5(5):735–747.
   PubMed Web of Science ®Google Scholar
• Lauer P, Rinaudo CD, Soriani M, et al. Genome analysis reveals pili in Group B Streptococcus. Science. 2005;309(5731):105.
   PubMed Web of Science ®Google Scholar
• Rosini R, Margarit I. Biofilm formation by Streptococcus agalactiae: influence of environmental conditions and implicated virulence factors. Front Cell Infect Microbiol. 2015;5:6.
   PubMed Web of Science ®Google Scholar
• Margarit I, Rinaudo CD, Galeotti CL, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009;199(1):108–115.
   PubMed Web of Science ®Google Scholar
• Sheppard AE, Vaughan A, Jones N, et al. Capsular typing method for streptococcus agalactiae using whole-genome sequence data. J Clin Microbiol. 2016;54(5):1388–1390.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Dangor Z, Heath PT, et al. Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants. Vaccine. 2013;31(Suppl 4):D52–7.
   PubMed Web of Science ®Google Scholar
• Heath PT. An update on vaccination against group B streptococcus. Expert Rev Vaccines. 2011;10(5):685–694.
   PubMed Web of Science ®Google Scholar
• Puopolo KM, Madoff LC, Eichenwald EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics. 2005;115(5):1240–1246.
   PubMed Web of Science ®Google Scholar
• Badri MS, Zawaneh S, Cruz AC, et al. Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. J Infect Dis. 1977;135(2):308–312.
   PubMed Web of Science ®Google Scholar
• Altaie SS, Dryja D. Detection of group B Streptococcus. Comparison of solid and liquid culture media with and without selective antibiotics. Diagn Microbiol Infect Dis. 1994;18(3):141–144.
   PubMed Web of Science ®Google Scholar
• Kwatra G, Adrian PV, Shiri T, et al. Serotype-specific acquisition and loss of group B streptococcus recto-vaginal colonization in late pregnancy. Plos One. 2014;9(6):e98778.
   PubMed Web of Science ®Google Scholar
• Gavino M, Wang E. A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization. Am J Obstet Gynecol. 2007;197(4):388–4.
   PubMed Web of Science ®Google Scholar
• Paoletti LC, Kasper DL. Conjugate vaccines against group B Streptococcus types IV and VII. J Infect Dis. 2002;186(1):123–126.
   PubMed Web of Science ®Google Scholar
• Banatvala JE, Brown DW. Rubella. Lancet. 2004;363(9415):1127–1137.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Castanon A, Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer. 2010;102(5):933–939.
   Web of Science ®Google Scholar
• Lischke JH, McCreight PH. Maternal group B streptococcal vertebral osteomyelitis: an unusual complication of vaginal delivery. Obstet Gynecol. 1990;76(3 Pt 2):489–491.
   PubMed Web of Science ®Google Scholar
• Aharoni A, Potasman I, Levitan Z, et al. Postpartum maternal group B streptococcal meningitis. Rev Infect Dis. 1990;12(2):273–276.
   PubMedGoogle Scholar
• Braun TI, Pinover W, Sih P. Group B streptococcal meningitis in a pregnant woman before the onset of labor. Clin Infect Dis. 1995;21(4):1042–1043.
   PubMed Web of Science ®Google Scholar
• Bobitt JR, Ledger WJ. Amniotic fluid analysis. Its role in maternal neonatal infection. Obstet Gynecol. 1978;51(1):56–62.
   PubMed Web of Science ®Google Scholar
• Fox BC. Delayed-onset postpartum meningitis due to group B streptococcus. Clin Infect Dis. 1994;19(2):350.
   PubMed Web of Science ®Google Scholar
• Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis. 1999;179(6):1410–1415.
   PubMed Web of Science ®Google Scholar
• Minkoff HL, Sierra MF, Pringle GF, et al. Vaginal colonization with Group B beta-hemolytic streptococcus as a risk factor for post-cesarean section febrile morbidity. Am J Obstet Gynecol. 1982;142(8):992–995.
   PubMed Web of Science ®Google Scholar
• Moller M, Thomsen AC, Borch K, et al. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet. 1984;2(8394):69–70.
   PubMed Web of Science ®Google Scholar
• Pass MA, Gray BM, Dillon HC Jr. Puerperal and perinatal infections with group B streptococci. Am J Obstet Gynecol. 1982;143(2):147–152.
   PubMed Web of Science ®Google Scholar
• Persson K, Christensen KK, Christensen P, et al. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis. 1985;17(2):195–199.
   PubMed Web of Science ®Google Scholar
• Sexton DJ, Rockson SG, Hempling RE, et al. Pregnancy-associated group B streptococcal endocarditis: a report of two fatal cases. Obstet Gynecol. 1985;66(3 Suppl):44S–7S.
   PubMed Web of Science ®Google Scholar
• Sutton GP, Smirz LR, Clark DH, et al. Group B streptococcal necrotizing fasciitis arising from an episiotomy. Obstet Gynecol. 1985;66(5):733–736.
   PubMed Web of Science ®Google Scholar
• Thomsen AC, Morup L, Hansen KB. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour. Lancet. 1987;1(8533):591–593.
   PubMed Web of Science ®Google Scholar
• Wood EG, Dillon HC Jr. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol. 1981;140(5):515–520.
   PubMed Web of Science ®Google Scholar
• Yancey MK, Duff P, Clark P, et al. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol. 1994;84(5):816–819.
   PubMed Web of Science ®Google Scholar
• Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41(6):25–32.
   PubMedGoogle Scholar
• Schwartz B, Schuchat A, Oxtoby MJ, et al. Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. Jama. 1991;266(8):1112–1114.
   PubMed Web of Science ®Google Scholar
• Opal SM, Cross A, Palmer M, et al. Group B streptococcal sepsis in adults and infants. Contrasts and comparisons. Arch Intern Med. 1988;148(3):641–645.
   PubMedGoogle Scholar
• Jackson LA, Hilsdon R, Farley MM, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123(6):415–420.
   PubMed Web of Science ®Google Scholar
• Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. N Engl J Med. 1993;328(25):1807–1811.
   PubMed Web of Science ®Google Scholar
• Artenstein MS, Gold R, Zimmerly JG, et al. Prevention of meningococcal disease by group C polysaccharide vaccine. N Engl J Med. 1970;282(8):417–420.
   PubMed Web of Science ®Google Scholar
• Keyserling H, Papa T, Koranyi K, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159(10):907–913.
   PubMed Web of Science ®Google Scholar
• Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). Morbidity, Mortality Weekly Review, CDC Centers for Disease and Prevention. 2008;57(17):462–465.
   Google Scholar
• Mohle-Boetani JC, Ajello G, Breneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J. 1993;12(7):589–593.
   PubMed Web of Science ®Google Scholar
• Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis. 1991;164(5):982–986.
   PubMed Web of Science ®Google Scholar
• Lamont HF, Blogg H, Lamont RF. Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity. Expert Opin Drug Saf. 2014;13:1569–1581.
   PubMed Web of Science ®Google Scholar
• Lamont RF, Sobel JD, Akins RA, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. Bjog. 2011;118(5):533–549.
   PubMed Web of Science ®Google Scholar
• Hakansson S, Kallen K, Bullarbo M, et al. Real-time PCR-assay in the delivery suite for determination of group B streptococcal colonization in a setting with risk-based antibiotic prophylaxis. J Maternal Fetal. 2014;27(4):328–332.
   PubMed Web of Science ®Google Scholar
• Bourgeois-Nicolaos N, Cordier AG, Guillet-Caruba C, et al. Evaluation of the Cepheid Xpert GBS assay for rapid detection of group B Streptococci in amniotic fluids from pregnant women with premature rupture of membranes. J Clin Microbiol. 2013;51(4):1305–1306.
   PubMed Web of Science ®Google Scholar
• Zusman AS, Baltimore RS, Fonseca SN. Prevalence of maternal group B streptococcal colonization and related risk factors in a Brazilian population. Braz J Infect Dis. 2006;10(4):242–246.
   PubMedGoogle Scholar
• Stapleton RD, Kahn JM, Evans LE, et al. Risk factors for group B streptococcal genitourinary tract colonization in pregnant women. Obstet Gynecol. 2005;106(6):1246–1252.
   PubMed Web of Science ®Google Scholar
• Hickman ME, Rench MA, Ferrieri P, et al. Changing epidemiology of group B streptococcal colonization. Pediatrics. 1999;104(2 Pt 1):203–209.
   PubMed Web of Science ®Google Scholar
• Meyn LA, Krohn MA, Hillier SL. Rectal colonization by group B Streptococcus as a predictor of vaginal colonization. Am J Obstet Gynecol. 2009;201(1):76–77.
   PubMed Web of Science ®Google Scholar
• Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis. 1990;162(3):672–677.
   PubMed Web of Science ®Google Scholar
• Newton ER, Butler MC, Shain RN. Sexual behavior and vaginal colonization by group B streptococcus among minority women. Obstet Gynecol. 1996;88(4 Pt 1):577–582.
   PubMed Web of Science ®Google Scholar
• Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994;16(2):374–402.
   PubMed Web of Science ®Google Scholar